ID27850A - Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung - Google Patents

Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung

Info

Publication number: ID27850A
Authority: ID; Indonesia
Prior art keywords: iskemia; injury; glucose; reduce heart; increasing reception
Prior art date: 1998-07-21

Application number

IDW20010151A

Other languages

English (en)

Indonesian (id)

Inventor

A M A Bril

Robin E Buckingham

Nassirah Khandoudi

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-21

Filing date

1999-07-21

Publication date

2001-04-26

1998-07-21 Priority claimed from GBGB9815871.0A external-priority patent/GB9815871D0/en

1998-07-21 Priority claimed from GBGB9815872.8A external-priority patent/GB9815872D0/en

1999-07-21 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2001-04-26 Publication of ID27850A publication Critical patent/ID27850A/id

Links

WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title 1
208000027418 Wounds and injury Diseases 0.000 title 1
230000006378 damage Effects 0.000 title 1
239000008103 glucose Substances 0.000 title 1
208000014674 injury Diseases 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Thiazole And Isothizaole Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

IDW20010151A 1998-07-21 1999-07-21 Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung ID27850A (id)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9815871.0A GB9815871D0 (en)	1998-07-21	1998-07-21	Novel compound
GBGB9815872.8A GB9815872D0 (en)	1998-07-21	1998-07-21	Novel method

Publications (1)

Publication Number	Publication Date
ID27850A true ID27850A (id)	2001-04-26

Family

ID=26314086

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW20010151A ID27850A (id)	1998-07-21	1999-07-21	Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung

Country Status (35)

Country	Link
EP (2)	EP1098638B1 (de)
JP (1)	JP2002521325A (de)
KR (1)	KR20010079550A (de)
CN (1)	CN1167416C (de)
AP (1)	AP1416A (de)
AR (1)	AR020614A1 (de)
AT (1)	ATE318588T1 (de)
AU (1)	AU5053599A (de)
BG (1)	BG105251A (de)
BR (1)	BR9912144A (de)
CA (1)	CA2338216A1 (de)
CO (1)	CO5060465A1 (de)
CY (1)	CY1106078T1 (de)
CZ (1)	CZ2001250A3 (de)
DE (1)	DE69930125T2 (de)
DK (1)	DK1098638T3 (de)
DZ (1)	DZ2854A1 (de)
EA (1)	EA004772B1 (de)
ES (1)	ES2259839T3 (de)
GC (1)	GC0000173A (de)
HU (1)	HUP0103870A3 (de)
ID (1)	ID27850A (de)
IL (1)	IL140741A0 (de)
MA (1)	MA26662A1 (de)
NO (1)	NO20010293L (de)
NZ (1)	NZ509175A (de)
OA (1)	OA11583A (de)
PE (1)	PE20000881A1 (de)
PL (1)	PL345663A1 (de)
PT (1)	PT1098638E (de)
SI (1)	SI1098638T1 (de)
SK (1)	SK1022001A3 (de)
TR (1)	TR200100208T2 (de)
TW (2)	TWI239836B (de)
WO (1)	WO2000004889A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6417212B1 (en)	1999-08-27	2002-07-09	Eli Lilly & Company	Modulators of peroxisome proliferator activated receptors
BR0017254A (pt) *	2000-06-16	2004-01-06	Smithkline Beecham Plc	Tratamento e prevenção de condições associadas à resistência cardìaca à insulina
JP4425628B2 (ja)	2001-07-23	2010-03-03	ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド	細胞保護化合物、薬学的処方物および美容用処方物、ならびに方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0842925A1 (de) *	1987-09-04	1998-05-20	Beecham Group Plc	Substituierte Thiazolidindionderivate
JPH05202042A (ja) *	1992-01-24	1993-08-10	Sankyo Co Ltd	糖尿病性合併症治療剤
GB9218830D0 (en) *	1992-09-05	1992-10-21	Smithkline Beecham Plc	Novel compounds
GB9611947D0 (en) *	1996-06-07	1996-08-07	Glaxo Group Ltd	Medicaments
US6277819B1 (en) *	1996-08-30	2001-08-21	Eli Lilly And Company	Use of GLP-1 or analogs in treatment of myocardial infarction
ID21778A (id) *	1996-09-12	1999-07-22	Sankyo Co	Zat peningkat aktifitas glutation reduktase yang mengandung troglitazon
WO1999025346A1 (en) *	1997-11-19	1999-05-27	Takeda Chemical Industries, Ltd.	Novel apoptosis inhibitors
AU2781899A (en) *	1998-02-24	1999-09-15	Trustees Of The University Of Pennsylvania, The	Use of a cardiac purinoceptor to effect cellular glucose uptake
WO1999059586A1 (en) *	1998-05-19	1999-11-25	Regents Of The University Of California	Thiazolidine and oxazolidine derivatives for the treatment of acute myocardial infarction and inhibition of cardiomyocyte apoptosis
US5968960A (en) *	1999-01-14	1999-10-19	The Regents Of The University Of California	Use of thiazolidinediones to ameliorate the adverse consequences of myocardial ischemia on myocardial function and metabolism

1999
- 1999-07-19 MA MA25690A patent/MA26662A1/fr unknown
- 1999-07-20 PE PE1999000726A patent/PE20000881A1/es not_active Application Discontinuation
- 1999-07-21 DE DE69930125T patent/DE69930125T2/de not_active Expired - Fee Related
- 1999-07-21 JP JP2000560882A patent/JP2002521325A/ja not_active Withdrawn
- 1999-07-21 EP EP99934911A patent/EP1098638B1/de not_active Expired - Lifetime
- 1999-07-21 GC GCP1999211 patent/GC0000173A/en active
- 1999-07-21 SI SI9930889T patent/SI1098638T1/sl unknown
- 1999-07-21 PL PL99345663A patent/PL345663A1/xx not_active Application Discontinuation
- 1999-07-21 TW TW088112356A patent/TWI239836B/zh not_active IP Right Cessation
- 1999-07-21 BR BR9912144-1A patent/BR9912144A/pt not_active IP Right Cessation
- 1999-07-21 CZ CZ2001250A patent/CZ2001250A3/cs unknown
- 1999-07-21 KR KR1020017000924A patent/KR20010079550A/ko not_active Ceased
- 1999-07-21 DK DK99934911T patent/DK1098638T3/da active
- 1999-07-21 PT PT99934911T patent/PT1098638E/pt unknown
- 1999-07-21 DZ DZ990154A patent/DZ2854A1/xx active
- 1999-07-21 OA OA1200100021A patent/OA11583A/en unknown
- 1999-07-21 HU HU0103870A patent/HUP0103870A3/hu unknown
- 1999-07-21 ID IDW20010151A patent/ID27850A/id unknown
- 1999-07-21 TR TR2001/00208T patent/TR200100208T2/xx unknown
- 1999-07-21 NZ NZ509175A patent/NZ509175A/en unknown
- 1999-07-21 CN CNB998089826A patent/CN1167416C/zh not_active Expired - Fee Related
- 1999-07-21 CO CO99045729A patent/CO5060465A1/es unknown
- 1999-07-21 WO PCT/GB1999/002358 patent/WO2000004889A1/en not_active Ceased
- 1999-07-21 IL IL14074199A patent/IL140741A0/xx unknown
- 1999-07-21 AR ARP990103577A patent/AR020614A1/es not_active Application Discontinuation
- 1999-07-21 TW TW092103470A patent/TW200307532A/zh unknown
- 1999-07-21 AT AT99934911T patent/ATE318588T1/de not_active IP Right Cessation
- 1999-07-21 AU AU50535/99A patent/AU5053599A/en not_active Abandoned
- 1999-07-21 EP EP04077992A patent/EP1523980A3/de not_active Withdrawn
- 1999-07-21 SK SK102-2001A patent/SK1022001A3/sk unknown
- 1999-07-21 ES ES99934911T patent/ES2259839T3/es not_active Expired - Lifetime
- 1999-07-21 CA CA002338216A patent/CA2338216A1/en not_active Abandoned
- 1999-07-21 AP APAP/P/2001/002033A patent/AP1416A/en active
- 1999-07-21 EA EA200100164A patent/EA004772B1/ru not_active IP Right Cessation
2001
- 2001-01-18 NO NO20010293A patent/NO20010293L/no unknown
- 2001-02-14 BG BG105251A patent/BG105251A/xx unknown
2006
- 2006-05-12 CY CY20061100616T patent/CY1106078T1/el unknown

Also Published As

Publication number	Publication date
CZ2001250A3 (cs)	2002-03-13
NZ509175A (en)	2003-10-31
NO20010293D0 (no)	2001-01-18
KR20010079550A (ko)	2001-08-22
DE69930125T2 (de)	2006-10-05
CN1310619A (zh)	2001-08-29
BG105251A (en)	2001-10-31
TW200307532A (en)	2003-12-16
TR200100208T2 (tr)	2001-05-21
EA004772B1 (ru)	2004-08-26
CY1106078T1 (el)	2011-06-08
DZ2854A1 (fr)	2003-12-01
SI1098638T1 (sl)	2006-06-30
ES2259839T3 (es)	2006-10-16
EP1523980A3 (de)	2009-03-18
HUP0103870A3 (en)	2003-06-30
EP1098638A1 (de)	2001-05-16
AP2001002033A0 (en)	2001-03-31
AP1416A (en)	2005-06-13
BR9912144A (pt)	2001-04-03
PT1098638E (pt)	2006-07-31
ATE318588T1 (de)	2006-03-15
CO5060465A1 (es)	2001-07-30
CN1167416C (zh)	2004-09-22
EA200100164A1 (ru)	2001-08-27
NO20010293L (no)	2001-03-07
OA11583A (en)	2004-07-01
CA2338216A1 (en)	2000-02-03
DE69930125D1 (de)	2006-04-27
PE20000881A1 (es)	2000-10-07
TWI239836B (en)	2005-09-21
SK1022001A3 (en)	2001-08-06
PL345663A1 (en)	2002-01-02
HUP0103870A2 (hu)	2002-05-29
EP1523980A2 (de)	2005-04-20
EP1098638B1 (de)	2006-03-01
GC0000173A (en)	2006-03-29
MA26662A1 (fr)	2004-12-20
AU5053599A (en)	2000-02-14
AR020614A1 (es)	2002-05-22
DK1098638T3 (da)	2006-06-19
IL140741A0 (en)	2002-02-10
WO2000004889A1 (en)	2000-02-03
JP2002521325A (ja)	2002-07-16

Publication	Publication Date	Title
ID28111A (id)	2001-05-03	Metoda untuk meningkatkan kesehatan kulit
DK1031346T3 (da)	2002-08-12	Ikke-invasiv vaccination gennem huden
DE60031836D1 (de)	2006-12-28	Hautpflegezubereitung die interzelluläre kommunikation vermittelt
ID28947A (id)	2001-07-19	Metode untuk meringankan inkontinensia uriner wanita
GB9914355D0 (en)	1999-08-18	Improvements relating to blood sampling devices
DE69829554D1 (de)	2005-05-04	Ovalgefortme herzkanüle
DK1051193T3 (da)	2006-06-12	Vandfrit topisk hudpræparat omfattende ketoconazol
EE200200203A (et)	2003-06-16	Südame arütmia ravis kasutatavad uued oksabispidiinühendid
FI970214A7 (fi)	1997-01-17	Droloksifeenin käyttö sydänverisuonitautien hoitamiseksi
DE69931855D1 (de)	2006-07-27	Hautpräparat
AU3876499A (en)	1999-11-23	Non-invasive measurement of blood glucose
EG22438A (en)	2003-02-26	Disposable pul-on garment having improved fitness to body
DE10084458T1 (de)	2002-04-25	Absorptionsfähige Gewebe zur Verbesserung der Hautschutzschicht
ID27867A (id)	2001-04-26	Benda-benda penyerap dapat dibuang yang melekat pada tubuh mempunyai suatu potongan tambahan yang sesuai dengan anatomi tubuh
AU2781899A (en)	1999-09-15	Use of a cardiac purinoceptor to effect cellular glucose uptake
GB0014617D0 (en)	2000-08-09	Improvements relating to lancets
DE10084499T1 (de)	2002-07-25	Absorptionsfähige Gewebe zur Verbesserung der Hautschutzschicht
ID25765A (id)	2000-11-02	Komposisi pembersih kulit
ITMI991895A0 (it)	1999-09-09	Depigmentanti cutanei
ID27850A (id)	2001-04-26	Penggunaan peningkat penerimaan glukosa untuk mengurangi cedera pasca-iskemia jantung
AU6941598A (en)	1999-10-18	Disposable garment having improved fitness to body during use
ID26986A (id)	2001-02-22	Penggunaan peningkat penerimaan glukosa untuk mengurangi apoptosis
FI4860U1 (fi)	2001-03-12	Reaktorin sydän
PT1192156E (pt)	2004-06-30	Novos compostos de bispidina uteis no tratamento de arritmias cardiacas
TW402904U (en)	2000-08-21	Improved structure of disposable dishes